Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

HR of hepatobiliary and pancreatic cancer’s subsite in the gallstone and cholecystectomy group

Variable Lagperiod (yr) PY Intrahepatic bileduct cancer Gallbladder cancer Extrahepatic bileduct cancer Ampulla of Vater cancer




Event HRa (95% CI) Event HRb (95% CI) Event HRc (95% CI) Event HRb (95% CI)
Gallstone
No lag period 76,200 41 2.32 (1.56-3.44) 84 3.60 (2.54-5.09) 32 2.81 (1.75-4.53) 7 1.81 (0.67-4.91)
1 year of lag 61,232 25 2.49 (1.64-3.78) 25 2.79 (1.82-4.27) 11 1.86 (0.99-3.50) 3 1.66 (0.53-5.21)
3 year of lag 37,102 11 1.84 (1.01-3.34) 13 1.97 (1.06-3.69) 6 1.46 (0.60-3.53) 3 2.67 (0.85-8.40)
5 year of lag 19,879 9 2.67 (0.98-4.17) 5 1.06 (0.34-3.29) 3 1.03 (0.26-4.14) 2 1.59 (0.22-11.38)
Cholecystectomy
No lag period 42,843 16 2.68 (1.63-4.40) 30 2.07 (1.14-3.75) 14 2.66 (1.44-4.89) 5 4.25 (0.74-10.40)
1 year of lag 34,156 15 2.86 (1.68-4.85) 7 1.60 (0.76-3.347) 6 1.41 (0.58-3.44) 4 4.16 (0.54-11.24)
3 year of lag 20,296 11 2.92 (1.51-5.64) 1 0.36 (0.05-2.57) 4 1.30 (0.41-5.90) 2 3.33 (0.83-13.45)
5 year of lag 10,618 7 4.08 (1.94-8.61) 0 - 3 1.46 (0.36-5.90) 1 3.02 (0.42-21.59)

HR, hazard ratio; PY, person year. aAdjusted sex, fatty liver disease. bAdjusted sex, diabetes. cAjusted sex, cirrhosis.

J Cancer Prev 2020;25:164~172 https://doi.org/10.15430/JCP.2020.25.3.164
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd